Pharvaris NV (PHVS)
38.65
+0.91
(+2.41%)
USD |
NASDAQ |
Sep 10, 11:46
Pharvaris Market Cap : 2.713B for Sept. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 09, 2026 | 2.650B |
| September 08, 2026 | 2.657B |
| September 04, 2026 | 2.475B |
| September 03, 2026 | 2.503B |
| September 02, 2026 | 2.469B |
| September 01, 2026 | 2.452B |
| August 31, 2026 | 2.430B |
| August 28, 2026 | 2.480B |
| August 27, 2026 | 2.598B |
| August 26, 2026 | 2.598B |
| August 25, 2026 | 2.614B |
| August 24, 2026 | 2.619B |
| August 21, 2026 | 2.546B |
| August 20, 2026 | 2.555B |
| August 19, 2026 | 2.546B |
| August 18, 2026 | 2.534B |
| August 17, 2026 | 2.480B |
| August 14, 2026 | 2.467B |
| August 13, 2026 | 2.390B |
| August 12, 2026 | 2.560B |
| August 11, 2026 | 2.416B |
| August 10, 2026 | 2.446B |
| August 07, 2026 | 2.451B |
| August 06, 2026 | 2.254B |
| August 05, 2026 | 2.186B |
| Date | Value |
|---|---|
| August 04, 2026 | 2.216B |
| August 03, 2026 | 2.110B |
| July 31, 2026 | 2.134B |
| July 30, 2026 | 2.217B |
| July 29, 2026 | 2.134B |
| July 28, 2026 | 2.201B |
| July 27, 2026 | 2.222B |
| July 24, 2026 | 2.236B |
| July 23, 2026 | 2.176B |
| July 22, 2026 | 2.248B |
| July 21, 2026 | 2.254B |
| July 20, 2026 | 2.195B |
| July 17, 2026 | 2.286B |
| July 16, 2026 | 2.202B |
| July 15, 2026 | 2.300B |
| July 14, 2026 | 2.252B |
| July 13, 2026 | 2.294B |
| July 10, 2026 | 2.294B |
| July 09, 2026 | 2.353B |
| July 08, 2026 | 2.350B |
| July 07, 2026 | 2.263B |
| July 06, 2026 | 2.173B |
| July 02, 2026 | 2.215B |
| July 01, 2026 | 2.221B |
| June 30, 2026 | 2.262B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novartis AG | 253.13B |
| BioAge Labs, Inc. | 399.17M |
| AstraZeneca PLC | 494.56B |
| ANI Pharmaceuticals, Inc. | 1.621B |
| Corcept Therapeutics, Inc. | 12.48B |
Market Cap Related Metrics
| Price to Book Value | 7.890 |
| Price | 38.65 |
| Earnings Yield | -7.89% |